Filing Flows › Outset Medical (OM) › Q3 2025
Outset Medical (OM) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 10, 2025
Outset Medical (OM) reported revenue of $29.4M for the third quarter 2025 (Q3 2025), +3% from a year earlier and -6% from the quarter before. Operating margin was -53.7%, net loss $17.8M (60.6% of revenue).
Outset Medical, Q3 2025: revenue $29.4M (+3% year over year), operating margin -53.7%, net loss $17.8M, operating cash flow −$6.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.4M | -6% | +3% |
| Operating profit | −$15.8M | — | — |
| Net earnings | −$17.8M | — | — |
| Operating cash flow | −$6.3M | — | — |
What changed
Revenue was $29.4M in Q3 2025, up 3% year over year and down 6% from the previous quarter. Consumables Product was the largest line at 42% of revenue. Consoles Product added $630K year over year (up 8%), 82% of the total change. Consumables Product declined 3%.
Gross margin was 39.4%, up 5.1 points from a year earlier. Operating costs exceeded revenue by $15.8M, an operating margin of -53.7%. Operating expenses fell 19% while revenue rose 3%. The quarter ended with a net loss of $17.8M, narrower than the previous quarter's $18.5M loss.
Operating cash flow was −$6.3M. Non-cash charges added back $1.0M of depreciation and amortization and $5.1M of share-based compensation. Working capital and other items added $5.4M. Capital expenditures of $160K exceeded it, leaving free cash flow of −$6.5M.
Questions
What was Outset Medical's revenue in the third quarter 2025?
Outset Medical (OM) reported revenue of $29.4M for the third quarter 2025 (Q3 2025), +3% from a year earlier and -6% from the quarter before.
Was Outset Medical profitable in the third quarter 2025?
Operating loss was $15.8M (-53.7% of revenue) and net loss $17.8M.
Source: Outset Medical 10-Q on SEC EDGAR.